Molecular mechanisms of Bcr-Abl-induced oncogenesis

被引：0
|
作者：
Gishizky, ML
机构：
来源：
CYTOKINES AND MOLECULAR THERAPY | 1996年 / 2卷 / 04期
关键词：
Bcr-Abl; chronic myelogenous leukemia; signal transduction; adaptor proteins; Grb2; shc; CrkL; tyrosine kinase;
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
The chimeric Bcr-Abl oncogene has been implicated in the pathogenesis of chronic myelogenous leukemia (CML) and Philadelphia chromosome (Ph1)-positive acute lymphocytic leukemia (ALL). The Bcr-Abl protein is a complex structure comprising discrete domains associated with specific biochemical and biological functions. These domains function through their ability to activate distinct signal transduction pathways responsible for Bcr-Abl's oncogenic behavior. This review will present our current understanding of signal transduction pathways involved in Bcr-Abl-induced pathophysiology, with particular emphasis on potential targets for therapeutic intervention.
引用
收藏
页码：251 / 261
页数：11
相关论文
共 50 条
  • [11] MAPK15 MEDIATES BCR-ABL-INDUCED AUTOPHAGY AND CELLULAR TRANSFORMATION
    Colecchia, David
    Chiariello, Mario
    ANTICANCER RESEARCH, 2014, 34 (10) : 5864 - 5864
  • [12] Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease
    Agarwal, Anupriya
    Bumm, Thomas G. P.
    Corbin, Arnie S.
    O'Hare, Thomas
    Loriaux, Marc
    VanDyke, Jonathan
    Willis, Stephanie G.
    Deininger, Jutta
    Nakayama, Keiichi I.
    Druker, Brian J.
    Deininger, Michael W.
    BLOOD, 2008, 112 (05) : 1960 - 1970
  • [13] PTEN is a tumor suppressor in CML stem cells and BCR-ABL-induced leukemias in mice
    Peng, Cong
    Chen, Yaoyu
    Yang, Zhongfa
    Zhang, Haojian
    Osterby, Lori
    Rosmarin, Alan G.
    Li, Shaoguang
    BLOOD, 2010, 115 (03) : 626 - 635
  • [14] Fyn is not essential for Bcr-Abl-induced leukemogenesis in mouse bone marrow transplantation models
    Doki, Noriko
    Kitaura, Jiro
    Uchida, Tomoyuki
    Inoue, Daichi
    Kagiyama, Yuki
    Togami, Katsuhiro
    Isobe, Masamichi
    Ito, Shinichi
    Maehara, Akie
    Izawa, Kumi
    Kato, Naoko
    Oki, Toshihiko
    Harada, Yuka
    Nakahara, Fumio
    Harada, Hironori
    Kitamura, Toshio
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (02) : 167 - 175
  • [15] Generation of a BCR-ABL-induced leukemia model in osteopontin-deficient mice.
    Flamant, Stephane
    Guillier, Martine
    Bonnet, Marie Laure
    Turhan, Ali G.
    BLOOD, 2006, 108 (11) : 417A - 417A
  • [16] Tracking the CD4+T cell response to BCR-ABL-induced leukemia
    Berquam-Vrieze, Katherine
    Farrar, Michael
    JOURNAL OF IMMUNOLOGY, 2013, 190
  • [17] BCR-ABL-Induced Downregulation of GADD45G in Chronic Myeloid Leukemia
    Casolari, Debora A.
    Ishiko, Jun
    Perugini, Michelle
    D'Andrea, Richard J.
    Melo, Junia V.
    BLOOD, 2012, 120 (21)
  • [18] IL-3 receptor signaling is dispensable for BCR-ABL-induced myeloproliferative disease
    Wong, S
    McLaughlin, J
    Cheng, DH
    Shannon, K
    Robb, L
    Witte, ON
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2003, 100 (20) : 11630 - 11635
  • [19] Fyn is not essential for Bcr-Abl-induced leukemogenesis in mouse bone marrow transplantation models
    Noriko Doki
    Jiro Kitaura
    Tomoyuki Uchida
    Daichi Inoue
    Yuki Kagiyama
    Katsuhiro Togami
    Masamichi Isobe
    Shinichi Ito
    Akie Maehara
    Kumi Izawa
    Naoko Kato
    Toshihiko Oki
    Yuka Harada
    Fumio Nakahara
    Hironori Harada
    Toshio Kitamura
    International Journal of Hematology, 2012, 95 : 167 - 175
  • [20] TIF1β promotes the development of BCR-ABL-induced myeloid leukemia.
    Morii, Mariko
    Sashida, Goro
    CANCER SCIENCE, 2021, 112 : 288 - 288
12345